Status:
RECRUITING
Automating Delirium Severity in the ICU
Lead Sponsor:
Mayo Clinic
Conditions:
Intensive Care Unit Delirium
Encephalopathy
Eligibility:
All Genders
50+ years
Brief Summary
The goal of this observational study is to develop a passive digital marker (PDM) for delirium severity and examine its performance in comparison to validated delirium severity tools in ICU patients \...
Detailed Description
Bedside cameras will stay up for at least 72 hours (about 3 days), it may be longer if delirium is being experienced and if the patient and or LAR (Legally Authorized Representative) agree to the came...
Eligibility Criteria
Inclusion
- • Age \>50;
- Estimated length of stay \>24 hours in ICU; and
- Are not admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.
Exclusion
- Admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.
- Admitted for acute neuronal injury
- Unable to communicate with research team due to sensory deficits (aphasic, blind, deaf) or language (does not speak English)
Key Trial Info
Start Date :
January 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 18 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06172491
Start Date
January 15 2023
End Date
December 18 2026
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905